# Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections

> **NCT03571100** · EARLY_PHASE1 · UNKNOWN · sponsor: **MidAtlantic Retina** · enrollment: 100 (estimated)

## Conditions studied

- Age-related Macular Degeneration
- Diabetic Vascular Diseases
- Proliferative Retinopathy
- Retina Vein Occlusion

## Interventions

- **DRUG:** Chlorhexidine
- **DRUG:** Povidine-Iodine

## Key facts

- **NCT ID:** NCT03571100
- **Lead sponsor:** MidAtlantic Retina
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-07
- **Primary completion:** 2019-05-06
- **Final completion:** 2019-05-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03571100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03571100, "Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03571100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*